APOE and Alzheimer disease: Consistent with this concept, human data demonstrate that compared to APOE3, female APOE4 AD patients have earlier onset of cognitive deficits (reviewed in [67]) and increased neuroinflammation, including increased activation of microglia and secretion of cytokines [7–10].